Section II
1441 – 1450 of 8712
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Short time to blood culture positivity in Enterococcus faecalis infective endocarditis
(
- Contribution to journal › Article
-
Mark
Modelers Modelling Models
(
- Contribution to journal › Article
-
Mark
Perinatal inflammation relates to early respiratory morbidity and lung function at 12 years of age in children born very preterm
(
- Contribution to journal › Article
-
Mark
Outcome of PCI with Xience versus other commonly used modern drug eluting stents : A SCAAR report
(
- Contribution to journal › Article
-
Mark
An experimental exposure study revealing composite airway effects of physical exercise in a subzero environment
(
- Contribution to journal › Article
-
Mark
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
Poor long-term prognosis in patients admitted with strong suspicion of acute myocardial infarction but discharged with another diagnosis
(
- Contribution to journal › Article
-
Mark
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months : follow-up of a longitudinal clinical study
(
- Contribution to journal › Letter
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
(
- Contribution to journal › Article
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter